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Nuclear proto-oncoprotems have been tmplicated in the regulation of gene expression by pepttdic hormones and growth factors durmg cell 
proliferation and differentiation. In the present study we have investigated m bovine adrenal cells (BAC) the effects of basic fibroblast growth factor 
(b-FGF), insulin-like growth factor 1 (IGF-I) and transforming growth factor/I (TGF-P) on C-Jun. JUn-B and c-fos mRNA levels and on cell growth 
and differentiation. Factors able to enhance the three proto-oncogenes (IGF-I, b-FGF and angiotensm II (A-II)) stimulate cell growth. whereas 
those inhibiting cell growth (TGF-/? and ACTH) decrease c-Jun mRNA level These results suggest that expression of c-Jun may be requtred to 
induce cell proliferation. The relation between proto-oncogenes and the expresston of differentiated functtons appears to be more complex. Whereas 
IGF-I. b-FGF and A-II increase the three nuclear proto-oncogenes. the effects of IGF-I and b-FGF on cytochrome P,,,, 17a-hydroxylase mRNA 
levels are opposite to those of A-II On the other hand, while TGF-/I and A-II have mhibttory effects on P,,,, 17~ mRNA level, they have opposite 
effects on c-jun mRNA 
Nuclear proto-oncogene, Proliferation; Differentiation 
1. INTRODUCTION 
Corticotropin (ACTH) and angiotensin-II (A-II) play 
a central role in the control of adrenal cell growth and 
function. In bovine adrenal fasciculata cells (BAC), A- 
II and ACTH not only cause an acute increase in ster- 
oidogenesis, but also have opposite, long-term effects 
on steroidogenic responsiveness and DNA synthesis. 
Whereas ACTH exerts long-term stimulatory influences 
on adrenal cell differentiated functions [ 1,2] and inhibits 
DNA synthesis [3,4], A-II inhibits differentiated func- 
tions [5,6] and increases DNA synthesis [7]. One mech- 
anism which has been proposed to link hormone-recep- 
tor interaction with long-term effects is the induction of 
transcription regulatory proteins, and in particular the 
Fos and Jun nuclear proto-oncoproteins [8]. In BAC, 
we have demonstrated that both hormones increase c- 
fos and jun-B mRNA levels, whereas they have opposite 
effects on c-jun mRNA levels, A-II being stimulatory 
and ACTH inhibitory [9]. 
In addition. BAC growth and function can be modu- 
lated by growth factors, specifically transforming 
growth factor (TGF-/31) [lo]. basic fibroblast growth 
factor (b-FGF) [11] and insulin-like growth factor 1 
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(IGF-I) [12]. In the present report, we have examined 
the effects of the different growth factors on c-fos. c-jun 
and jun-B nuclear proto-oncogene mRNA levels, and 
have tried to establish a correlation between the early 
proto-oncogene regulation and the biological processes, 
namely differentiation and proliferation. 
2. MATERIALS AND METHODS 
Synthetic A-II was obtamed from Bachem (Bubendorf, Switzer- 
land): corttcotropin (ACTH) (Synacthen) from CIBA (Rueil-Malmai- 
son, France) and porcine TGF-/?l from R&D Systems Inc. (Mmnea- 
polis. MN, USA). Human recombinant IGF-I was a gift of Dr. L. 
Fryklund and R Gunnarson. Kabi (Stockholm, Sweden), and recom- 
binant bFGF of Dr. M T Tauber (Toulouse. France) Insulm and 
transferrm were obtained from Sigma Chemtcals Co. (St LOUIS, MO): 
Ham’s F-12 medium and Dulbecco’s modified Eagle’s medium 
(DMEM) in powder form. nystatm. penicillmlstreptomycin. trypsin/ 
EDTA, fetal calf serum from Gtbco (Paris. France). Mouse c-Jun and 
Jun-B cDNAs were kindly provided by Dr. I Verma (Salk Institute, 
San Diego. CA) [13] and Dr. D. Nathans (Johns Hopkins. Balttmore, 
MD) [14]. respectively. Rat glyceraldehyde-3-phosphate-dehydroge- 
nase (GAPDH) cDNA and cytochrome Pail, 17a hydroxylase (P,,, 
17a) cDNA were gifts from Dr. J.M Blanchard (Montpelher. France) 
[15] and Dr. M R. Waterman (Dallas. USA) [16], respecttvely. c-fos 
was purchased from Oncor (Gaithersburg. MD). 
2.1. Cell rsolution and culture 
BAC were prepared by sequential treatment of adrenal corttcal 
slices with trypsm (0.19%) as previously described [6,9]. The cells were 
cultured in a chemically defined medium. Ham’sFlZlDMEM (I, 1). 
containing transferrin (10,uglml). msulin (5pg/ml). vitamm C (IO-” M) 
and antibiotics. The experiments were carried out on cells cultured for 
4 days. 
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2.2. RNA uolutlo?l and Northern- and slot-blot analws Table I 
For each treatment, the culture medium was removed from 25 cm’ 
flasks. cells were harvested in guanidine thiocyanate. and total RNA 
was extracted according to the method of Chomczynski and Sacchi 
[17]. For Northern blot analysis, total cytoplasmic RNA (10 pg) was 
subjected to electrophoresis through 1% agarose gels and transferred 
under vacuum to Hybond-N nylon membrane (Amersham. UK) For 
each sample analysed by slot-blot, mcreasmg amounts of total cyto- 
plasmic RNA (I-8 pg) were transferred directly to Hybond-N nylon 
membrane by using a multiwell filtration manifold (BRL). Mem- 
branes with bound RNA were baked at 80°C to cross-link the RNA 
to the filters. Hybridization with DNA “P-1abelled probes and the 
analysis of blots were carried out as previously described [9]. 
Effect of growth factors on [‘Hlthymidine incorporation into BAC 
DNA 
- Insulin + Insulin 
Analysis of each Northern blot was realized m duphcate. The den- 
sitometric values for the proto-oncogene mRNA levels were normal- 
ized to those for GAPDH to control for quantity of RNA transferred 
to the blot. 
Control 810 ?Z 120 4,500 * 340b 
b-FGF 10 ng/ml 18,500 ? 800” 32,400 ? 1 .200”,b 
IGF-I 50 &ml 5.200 f 460” 5,400 + 350 
TGF-/? 1 ng/ml 790 * 140 3,100 * 210”.b 
d P < 0.05 compared to Control of the same column. 
b P < 0.001 compared to values of the same line. 
Cells were seeded at 2 x IO’ cells/well in complete medium supple- 
mented with 0.5% fetal calf serum (FCS). Then the medium was 
removed and replaced by fresh medium (Deprivation medium: with- 
out FCS and without Insulin). After 24 h the medium was replaced 
by fresh medium without or with insulm (10 pg/ml) in the absence 
or presence of the Indicated growth factor. After 8 h [jH]thymidme 
1 &X/ml was added and the Incubation contmued for 18-20 h. The 
incorporation of [‘Hlthymidine into DNA was measured as indicated 
in section 2. The results are the mean ? S.E.M. of three experiments 
2.3. [3H]Th~m~ditze bzcorporatzon Into DNA 
About 8 h after the addition of growth factors, [‘Hlthymidine (1 
@i/ml) was added and the incubation contmued for 18-20 h. At the 
end of this period. the medium was removed. the cells were washed 
three times with 5% trichlordcetic acid, and solubihzed m 0.5 N 
NaOH. 0.4% deoxycholate Counting was carried out for 10 mm in 
a liquid scintillation spectrometer with an efficiency of 65%. 
2.4. Statistrcs 
Data are reported as the mean ? S.E.M. for a minimum of three 
different cell preparations. Statistical significance was determmed with 
Student’s t-test. The null hypothesis was rejected when P < 0.05 was 
obtained. 
3. RESULTS 
In the first series of experiments, we investigated the 
acute effects of the different growth factors on proto- 
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Fig. 1. Effects of growth factors on proto-oncogene mRNAs. On the 
fourth day of culture cells were incubated for one hour with fresh 
medium without (open bar) or with TGF-/T (1 @ml) (thin hatched 
bar), b-FGF (10 r&ml) (filled bar), IGF-I (50 @ml) (wide hatched 
bar). The cells were harvested, the RNA extracted, and 10 pug RNA/ 
lane were electrophoresed, transferred to nylon membrane, and hy- 
bridized as outlined m section 2. (Top panel) Mean f SE M. of 3-11 
experiments. Values with different letters are sigmficantly different. 
(Lower panel) Representative Northern blots. 
cpmlwell 
oncogene mRNA levels (Fig. 1). The maximally active 
concentration for each growth factor, as well as the time 
required to induce proto-oncogene mRNA change, 
were determined in preliminary experiments (data not 
shown). Both IGF-I and b-FGF significantly increased 
(P < 0.05) the mRNA levels of the three proto-onco- 
genes, although the effects of b-FGF were consistently 
higher than those induced by IGF-I. In contrast, TGF-p 
significantly reduced c-jun mRNA levels, had no effect 
on c-fos, and stimulated jun-B mRNA. 
Since the proteins encoded by the proto-oncogenes 
might play a role in the long-term response of cells to 
several stimuli, we investigated the effects of growth 
factors on BAC growth and differentiation. In the ab- 
sence of insulin, b-FGF, and to a lesser extent IGF-I, 
enhanced [3H]thymidine incorporation into DNA. 
whereas TGF-/? had no effect (Table I). Insulin alone at 
micromolar concentrations, had a significant stimula- 
tory effect, similar to that induced by IGF-I at nanomo- 
lar concentrations, suggesting that the mitogenic effect 
of insulin at this concentration was mediated through 
IGF type I receptors. This was confirmed by the fact 
that when both peptides were added together the effects 
were similar to those induced by each peptide alone. 
The mitogenic effect of b-FGF was, however, potenti- 
ated by insulin. In contrast, TGF-/I slightly but signifi- 
cantly inhibited the mitogenic action of insulin (Table 
I) and that of b-FGF (data not shown). 
The effects of growth factors on BAC differentiation 
were evaluated by measuring the mRNA levels of cyto- 
chrome P450 17c+hydroxylase, a specific marker of BAC 
differentiation (Fig. 2). Insulin at micromolar concen- 
trations enhanced P,,, 17a: mRNA levels about 2-fold. 
IGF-I (50 ng/ml) produced similar effects (data not 
shown). In the presence of insulin, b-FGF further en- 
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CONT TGF.f3 b-FGF -INS 
Ftg. 2. Effects of growth factors on P450 17~ mRNA level. Cells were 
mcubated for 36 h with fresh medtum without (-INS) or wtth ins&n 
C IO ,f.@nl) alone ICONT). or supplemented with TGF,B f 1 ng./ml) or 
b-FGFIIO @ml). Three ahquots of lOpug RNA were electrophoresed, 
transferred to nylon membrane, and hybndtzed as outlined in section 
2. (Top panel) Densrtometric scanning of 4 dtfferent experiments 
(mean Y?I S E.M.). "P < 0 05 compared tocontrol. (Lower panel) Rcp- 
resentattve Northern blot 
hanced PdsO 17~ mRNA levels. whereas TGF-/3 caused 
a 50% decrease. 
In order to investigate the long-term effect of growth 
factors on BAC responsiveness to specific peptidic 
hormones, cells were pretreated for 36 h with either the 
standard culture medium containing insulin or with me- 
dium supplemented with b-FGF or TGF-/?. and then 
stimulated with ACTH or A-II. The results of Figs. 3 
and 4 show that pretreatment with b-FGF decreases the 
basal level of the three proto-oncogene mRNAs, but 
significantly enhanced the stimulatory effects of both 
ACTH and A-II on jun-B and c-fos mRNAs. Pretreat- 
ment with TGF-/? reduced proto-oncogene mRNA lev- 
els both under basal conditions and following ACTH or 
A-II stimulation, but none of these values were statisti- 
cally different from the corresponding values of cells 
cultured in the standard culture medium. 
The steroidogenic responsiveness of BAC to both 
ACTH and A-II was also modified by pretreatment 
with growth factors (Table II). Insulin and IGF-I simi- 
larly enhanced the response to both hormones. b-FGF 
further enhanced the effects of insulin, and TGF-/I com- 
pletely blocked the effects of insulin. Indeed, the ster- 
oidogenic response of cells pretreated with insulin plus 
TGF-fl was even lower than that of cells cultured in the 
absence of insulin. 
4. DISCUSSION 
Evidence has accumulated over the last 5 years that 
supports the concept that nuclear proto-oncoproteins 
are part of a complex network of signal transduction 
systems. and that they might be involved in the regula- 
tion of cell growth and differentiation by peptide 
hormones and growth factors (reviewed in [l&19]). 
Therefore, in the present study, we have investigated the 
effects of three growth factors on c-jun. c-fos and jun-B 
mRNA levels, cell growth. and cell differentiation using 
a well-ditTerentiated cell type. Both IGF-I and b-FGF 
acutely increased the proto-oncogene mRNA levels. 
and enhanced DNA synthesis and cytochrome P,,, 17a 
mRNA levels, a very specific marker of adrenal cell 
differentiation [16,20]. in a long-term manner. Moreo- 
ver, pretreatment with both IGF-I and b-FGF en- 
hanced the biological response (cortisol production) to 
ACTH and A-II, the two specific hormones that regu- 
late adrenocortical secretion. It is likely that the in- 
creased responsiveness of cells pretreated with growth 
factors is not only due to an increase in Pd5,) 17~1, but 
also to an increased expression of genes encoding the 
receptors for both hormones, since at least IGF-I in- 
creases the receptor number for both hormones ]19.31]. 
ALthough the effects of both growth factors are thought 
to be mediated by specific membrane tyrosine kinase 
receptors [Xl, the effects of b-FGF on cell parameters 
studied were higher than those induced by IGF-I. 
The TGF-P receptor has been recently cloned [23,24], 
but its mechanism of action still remains unknown [25]. 
In BAC, TGF-/3 increased jun-B mRNA, but either had 
no effect or decreased the mRNA levels of c-fos and 
c-jun, respectively, and these early effects were associ- 
ated with long-term inhibition of cell growth and differ- 
entiation. The inhibitory effects of TGF-/? on Peso 17~. 
similar to that previously reported [26,77], is one of the 
jun_B 
c_ jun 
cfos 
123456789 
Fig. 3. Effects ofIong-term treatment wtth growth factors on basal and 
ACTH- or A-II-stimulated proto-oncogene mRNA levels; representa- 
tive Northern blots. On the fourth day ofculture. cells were incubated 
for 36 h with fresh medmm wnhout (lanes l-3) or utth TGF-B 1 &ml 
(lanes 4-6). b-FGF 10 ngiml (lanes 7-9). After this pretreatment the 
medrum was changed and replaced by fresh medmm without (lanes 
1.4.7) or with lo-’ M A-II (lanes 2.5.8). or IO-’ M ACTH (lanes 3,6,9) 
for 1 h. The cells were then harvested and the RNA extracted. and 10 
pg RNA/lane electrophoresed, transferred to nylon membrane, and 
hybridized as outlmed m section 1. 
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Fig. 4 Effects of long-term treatment with growth factors on basal and A-II- or ACTH-stimulated proto-oncogene mRNA levels; results of 
densitometric scanning of Northern blots. On the fourth day of culture. cells were Incubated for 36 h with fresh medium without (control, open 
bar) or with TGF-P 1 ng/ml (hatched bar), b-FGF 10 ng/ml (filled bar) After this pretreatment the medium was changed and replaced by fresh 
medium without (BASAL) or with lo-’ M A-II. or lOmy M ACTH for 1 h. The cells were then harvested, the RNA extracted. and 1Ohg RNA/lane 
electrophoresed, transferred to nylon membrane, and hybridized as outlined in section 2. The results are the mean 2 S.E.M. of 3-9 different 
experiments, “P < 0.05 compared to control/basal. ‘f’ < 0.05 compared to control/A-II. 'P < 0.05 compared to control/ACTH. 
pleiotropic inhibitory effects of this peptide on adrenal 
cells [28,29], which explains the very low responsiveness 
of TGF-B-pretreated cells to both ACTH and A-II. 
Taken together, the above results indicate that factors 
able to enhance the three proto-oncogenes, stimulate 
cell growth. This conclusion is confirmed by the fact 
that A-II, which enhanced the expression of the three 
proto-oncogenes ([9] and present data), also has a mito- 
genie action on BAC [7]. On the other hand, ACTH, 
which stimulates the expression of jun-B and c-fos ([9] 
and present data) but decreases c-jun, and TGF-p, 
which also decreases c-jun, inhibit cell multiplication 
[3,4]. These results therefore suggest that expression of 
c-jun may be required to induce cell multiplication. In 
favour of this hypothesis are recent data showing that 
over-expression of c-jun induces cell multiplication [30]. 
The relationship between proto-oncogenes and the 
expression of differentiated functions appears to be 
more complex. In BAC, ACTH enhances transcription 
of the genes encoding the enzymes of the steroidogenic 
pathway (cytochrome P,,, 17a, P,,, 2 1 -hydroxylase and 
P,,, cholesterol side chain cleavage) [20] through CAMP. 
The upstream regions of these genes have been found 
to contain unique CAMP-responsive sequences not ob- 
served in other genes for which transcription is regu- 
lated by CAMP [31]. Thus in BAC, both inhibition of 
cell growth [4] and differentiation (P,,, 17~~) can be di- 
rectly regulated by CAMP. No classical AP-1 binding 
site has been found in the S-flanking region of P,,, 1701 
[32], but it is known that the homodimer (Jun) and 
heterodimer (Fos/Jun) of proto-oncoproteins may bind 
to sequences other than the classical (TGACTCA) AP-1 
binding site [18]. Moreover, if the proto-oncoproteins 
(homo and/or heterodimer) are involved in the regula- 
tion of P,,, 17~ it remains to be explained why the 
effects of IGF-I and b-FGF are opposite to those of 
A-II, whereas the effects of the three growth factors on 
Table II 
Long-term effects of growth factors on the steroidogemc responsive- 
ness of BAC to ACTH and A-II 
Cortisol production 
(ng/lO’ cells/2 h) 
ACTH A-II 
Control 482 4 512 5” 
IGF-I (50 ng/ml) 165 f 15” 154 f lib 
Insulm ( 10 fig/ml) 158 2 I@ 148 t 15b 
Insulin + b-FGF (10 ng/ml) 225 f 12’ 214 f 13 
Insulin + TGF-p (1 ng/ml) 22 + 4d 19f 3d 
Cells were cultured for 36 h with the indicated factors. Then the 
medium was removed and ceils were stimulated with IOm9 M ACTH 
or lo-’ M A-II for 2 h. after which cortisol was measured in the 
medium. Means bearing different superscripts are significantly differ- 
ent (P < 0.05). The results are the mean f S.E.M. of three experi- 
ments. 
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proto-oncogene mRNAs are all stimulatory. Since in 
some cell models the effects of jun-B and c-jun may be 
antagonistic [33], a difference in action between these 
proto-oncoproteins could explain the above discrep- 
ancy. It also remains to be demonstrated whether the 
inhibitory effect of TGF-P on P,,, 17cl expression is 
solely related to its effect on proto-oncogenes. To clarify 
the potential role of proto-oncogenes on the expression 
of genes encoding for BAC differentiated functions, we 
have started transfection experiments with these proto- 
oncogenes. either alone or in combination. 
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